01 PIERRE FABRE MEDICAMENT Gaillac FR (1)
02 Pierre Fabre Medicament Gaillac FR (1)
03 Pierre Fabre Santé - Plantes & Industrie Gaillac FR (1)
01 MicroCrystalline Hydroxyapatite Compound (1)
02 Ossein Hydroxyapatite Compound (2)
01 France (3)
01 Valid (2)
02 Withdrawn by Holder (1)
15
PharmaCompass offers a list of HYDROXYPROPYLMETHYLCELLULOSE API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right HYDROXYPROPYLMETHYLCELLULOSE manufacturer or HYDROXYPROPYLMETHYLCELLULOSE supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred HYDROXYPROPYLMETHYLCELLULOSE manufacturer or HYDROXYPROPYLMETHYLCELLULOSE supplier.
PharmaCompass also assists you with knowing the HYDROXYPROPYLMETHYLCELLULOSE API Price utilized in the formulation of products. HYDROXYPROPYLMETHYLCELLULOSE API Price is not always fixed or binding as the HYDROXYPROPYLMETHYLCELLULOSE Price is obtained through a variety of data sources. The HYDROXYPROPYLMETHYLCELLULOSE Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Hydroxyapatite manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Hydroxyapatite, including repackagers and relabelers. The FDA regulates Hydroxyapatite manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Hydroxyapatite API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Hydroxyapatite supplier is an individual or a company that provides Hydroxyapatite active pharmaceutical ingredient (API) or Hydroxyapatite finished formulations upon request. The Hydroxyapatite suppliers may include Hydroxyapatite API manufacturers, exporters, distributors and traders.
click here to find a list of Hydroxyapatite suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Hydroxyapatite CEP of the European Pharmacopoeia monograph is often referred to as a Hydroxyapatite Certificate of Suitability (COS). The purpose of a Hydroxyapatite CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Hydroxyapatite EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Hydroxyapatite to their clients by showing that a Hydroxyapatite CEP has been issued for it. The manufacturer submits a Hydroxyapatite CEP (COS) as part of the market authorization procedure, and it takes on the role of a Hydroxyapatite CEP holder for the record. Additionally, the data presented in the Hydroxyapatite CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Hydroxyapatite DMF.
A Hydroxyapatite CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Hydroxyapatite CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Hydroxyapatite suppliers with CEP (COS) on PharmaCompass.
We have 1 companies offering Hydroxyapatite
Get in contact with the supplier of your choice: